- Home
- KTF vs PRQR Comparison
KTF vs PRQR Comparison
Compare KTF & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTF
- PRQR
- Stock Information
- Founded
- KTF 1988
- PRQR 2012
- Country
- KTF United States
- PRQR Netherlands
- Employees
- KTF N/A
- PRQR N/A
- Industry
- KTF Finance Companies
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- KTF Finance
- PRQR Health Care
- Exchange
- KTF Nasdaq
- PRQR Nasdaq
- Market Cap
- KTF 350.7M
- PRQR 309.5M
- IPO Year
- KTF N/A
- PRQR 2014
- Fundamental
- Price
- KTF $8.96
- PRQR $1.14
- Analyst Decision
- KTF
- PRQR Strong Buy
- Analyst Count
- KTF 0
- PRQR 6
- Target Price
- KTF N/A
- PRQR $8.50
- AVG Volume (30 Days)
- KTF 103.3K
- PRQR 628.0K
- Earning Date
- KTF 01-01-0001
- PRQR 05-08-2025
- Dividend Yield
- KTF 3.54%
- PRQR N/A
- EPS Growth
- KTF N/A
- PRQR N/A
- EPS
- KTF 0.39
- PRQR N/A
- Revenue
- KTF N/A
- PRQR $20,235,014.00
- Revenue This Year
- KTF N/A
- PRQR $6.44
- Revenue Next Year
- KTF N/A
- PRQR N/A
- P/E Ratio
- KTF $23.10
- PRQR N/A
- Revenue Growth
- KTF N/A
- PRQR 196.41
- 52 Week Low
- KTF $7.40
- PRQR $1.07
- 52 Week High
- KTF $9.12
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- KTF 33.80
- PRQR 28.23
- Support Level
- KTF $8.93
- PRQR $1.08
- Resistance Level
- KTF $9.03
- PRQR $1.26
- Average True Range (ATR)
- KTF 0.13
- PRQR 0.13
- MACD
- KTF -0.02
- PRQR 0.02
- Stochastic Oscillator
- KTF 28.00
- PRQR 21.87
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.